v3.26.3
Note 9 - Segment Information - Operations by Business Segment (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Jun. 30, 2026
Sales, net $ 9,913 $ 12,689  
Cost of sales 10,025 11,670  
Gross profit (loss) (112) 1,019  
Depreciation 67 77  
Capital Expenditures 124 173  
Assets 24,027   $ 25,338
Contract Manufacturing [Member]      
Sales, net 9,624 12,167  
Cost of sales 9,702 11,193  
Gross profit (loss) (78) 974  
Depreciation 65 77  
Capital Expenditures 124 165  
Assets 20,142    
Other Nutraceutical Business [Member]      
Sales, net 289 522  
Cost of sales 323 477  
Gross profit (loss) (34) 45  
Depreciation 2 0  
Capital Expenditures 0 8  
Assets 3,885    
UNITED STATES      
Sales, net 7,710 10,653  
Assets     25,338
UNITED STATES | Contract Manufacturing [Member]      
Sales, net 7,421 10,131  
Assets     21,826
UNITED STATES | Other Nutraceutical Business [Member]      
Sales, net 289 522  
Assets     $ 3,512
Non-US [Member]      
Sales, net 2,203 2,036  
Non-US [Member] | Contract Manufacturing [Member]      
Sales, net 2,203 2,036  
Non-US [Member] | Other Nutraceutical Business [Member]      
Sales, net $ 0 $ 0